BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) announced a monthly dividend on Friday, June 5th. Stockholders of record on Tuesday, September 15th will be paid a dividend of 0.11 per share on Wednesday, September 30th. This represents a c) dividend on an annualized basis and a dividend yield of 8.0%. The ex-dividend date is Tuesday, September 15th.
BlackRock Health Sciences Term Trust Price Performance
NYSE:BMEZ opened at $16.47 on Friday. BlackRock Health Sciences Term Trust has a twelve month low of $13.70 and a twelve month high of $17.25. The company’s 50 day moving average is $16.07 and its two-hundred day moving average is $15.00.
Institutional Investors Weigh In On BlackRock Health Sciences Term Trust
A number of large investors have recently bought and sold shares of the company. Kestra Advisory Services LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter worth $26,000. SouthState Bank Corp purchased a new position in BlackRock Health Sciences Term Trust during the first quarter valued at approximately $29,000. PNC Financial Services Group Inc. purchased a new stake in BlackRock Health Sciences Term Trust in the 1st quarter worth approximately $35,000. Geneos Wealth Management Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter valued at approximately $40,000. Finally, Integrated Wealth Concepts LLC purchased a new stake in BlackRock Health Sciences Term Trust during the second quarter worth $46,000.
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Nasdaq’s $100 Million Kraken Bet Prepares It for a Market That Never Closes
- Copper’s Record Rally Highlights a Deeper Supply Problem
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
